90811-1 |
Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor 1 Ab |
PrThr |
CSF |
Pt |
Ord |
CBA IFA |
|
ACTIVE |
AMPAR1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
90811-1 |
|
CBA IFA |
|
|
Both |
|
|
|
0 |
AMPAR1 Ab CSF Ql CBA IFA |
|
|
|
|
|
ABS; Aby; Alfa; AMPA Receptor; AMPAR1; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; GluA1; GluR1; GluR-A; Hydrox; i; III; Indirect Fluorescence Antibody; Limbic encephalitis; OH; Ordinal; Point in time; PR; QL; Qual; Qualitative; Quisqualate Receptor; Random; Rec; Recept; Receptors; Recp; Recptr; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid |
2.69 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
90812-9 |
Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor 1 Ab |
Titr |
CSF |
Pt |
SemiQn |
CBA IFA |
|
ACTIVE |
AMPAR1 Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
SERO |
|
90812-9 |
|
CBA IFA |
|
|
Both |
|
|
|
0 |
AMPAR1 Ab Titr CSF CBA IFA |
|
|
|
|
|
ABS; Aby; Alfa; AMPA Receptor; AMPAR1; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Dilution factor; Dilution Factor (Titer); GluA1; GluR1; GluR-A; Hydrox; i; III; Indirect Fluorescence Antibody; Limbic encephalitis; OH; Point in time; Quisqualate Receptor; Random; Rec; Recept; Receptors; Recp; Recptr; Serology; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Titer; Titered; Titre; Ttr |
2.75 |
2.65 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
90813-7 |
Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor 2 Ab |
PrThr |
CSF |
Pt |
Ord |
CBA IFA |
|
ACTIVE |
AMPAR2 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
90813-7 |
|
CBA IFA |
|
|
Both |
|
|
|
0 |
AMPAR2 Ab CSF Ql CBA IFA |
|
|
|
|
|
ABS; Aby; Alfa; AMPA Receptor; AMPAR2; AMPAR2 Ab; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; GluA2; GluR2; GluR-B; Hydrox; II; III; Indirect Fluorescence Antibody; Limbic encephalitis; OH; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Rec; Recept; Receptors; Recp; Recptr; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid |
2.69 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
90814-5 |
Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor 2 Ab |
Titr |
CSF |
Pt |
SemiQn |
CBA IFA |
|
ACTIVE |
AMPAR2 Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
SERO |
|
90814-5 |
|
CBA IFA |
|
|
Both |
|
|
|
0 |
AMPAR2 Ab Titr CSF CBA IFA |
|
|
|
|
|
ABS; Aby; Alfa; AMPA Receptor; AMPAR2; AMPAR2 Ab; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Dilution factor; Dilution Factor (Titer); GluA2; GluR2; GluR-B; Hydrox; II; III; Indirect Fluorescence Antibody; Limbic encephalitis; OH; Point in time; Random; Rec; Recept; Receptors; Recp; Recptr; Serology; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Titer; Titered; Titre; Ttr |
2.75 |
2.65 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
90815-2 |
Amphiphysin Ab |
PrThr |
CSF |
Pt |
Ord |
IF |
|
ACTIVE |
Amphiphysin Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
90815-2 |
|
IF |
|
|
Both |
|
|
|
0 |
Amphiphysin Ab CSF Ql IF |
|
|
|
|
|
ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; breast cancer; Cerebral spinal fluid; Cerebrospinal Fl; FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Neuro; Neurology; Ordinal; Paraneoplastic syndrome; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Stiff Man Syndrome; Time Resolved Fluorescence; TRF |
2.65 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
90816-0 |
Amphiphysin Ab |
ACnc |
CSF |
Pt |
Qn |
Line blot |
|
ACTIVE |
Amphiphysin Ab [Units/volume] in Cerebral spinal fluid by Line blot |
|
MIN |
DefinitionDescription |
|
|
arb U/L |
|
|
|
|
|
|
SERO |
|
90816-0 |
|
Line blot |
|
|
Both |
|
|
|
0 |
Amphiphysin Ab CSF Line blot-aCnc |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; breast cancer; Cerebral spinal fluid; Cerebrospinal Fl; Paraneoplastic syndrome; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Stiff Man Syndrome |
2.7 |
2.65 |
|
|
|
|
|
|
|
[arb'U]/L |
|
|
|
0 |
90817-8 |
Aquaporin 4 water channel Ab |
PrThr |
CSF |
Pt |
Ord |
IF |
|
ACTIVE |
Aquaporin 4 water channel Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
90817-8 |
|
IF |
|
|
Both |
|
|
|
0 |
AQP4 H2O channel Ab CSF Ql IF |
|
|
|
|
|
ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; AQP4; AQP4 H2O channel; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Devic's disease; FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Neuromyelitis optica; NMO; NMO spectrum disorders; NMOSD; Opticospinal multiple sclerosis; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; TRF; Water channel aquaporin-4 |
2.67 |
2.65 |
|
|
|
|
|
|
|
|
|
|
Release 2.67: COMPONENT: Updated "receptor" to "water channel" per current scientific nomenclature |
0 |
90818-6 |
Aquaporin 4 water channel Ab.IgG |
PrThr |
CSF |
Pt |
Ord |
CBA IFA |
|
ACTIVE |
Aquaporin 4 water channel IgG Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
90818-6 |
|
CBA IFA |
|
|
Both |
|
|
|
0 |
AQP4 H2O channel IgG CSF Ql CBA IFA |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; AQP4; AQP4 H2O channel; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Devic's disease; Immune globulin G; Immunoglobulin G; Indirect Fluorescence Antibody; Neuromyelitis optica; NMO; NMO spectrum disorders; NMOSD; Opticospinal multiple sclerosis; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Water channel aquaporin-4 |
2.69 |
2.65 |
|
|
|
|
|
|
|
|
|
|
Release 2.67: COMPONENT: Updated "receptor" to "water channel" per current scientific nomenclature |
0 |
90819-4 |
Aquaporin 4 water channel Ab.IgG |
Titr |
CSF |
Pt |
SemiQn |
CBA IFA |
|
ACTIVE |
Aquaporin 4 water channel IgG Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
SERO |
|
90819-4 |
|
CBA IFA |
|
|
Both |
|
|
|
0 |
AQP4 H2O channel IgG Titr CSF CBA IFA |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; AQP4; AQP4 H2O channel; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Devic's disease; Dilution factor; Dilution Factor (Titer); Immune globulin G; Immunoglobulin G; Indirect Fluorescence Antibody; Neuromyelitis optica; NMO; NMO spectrum disorders; NMOSD; Opticospinal multiple sclerosis; Point in time; Random; Serology; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Titer; Titered; Titre; Ttr; Water channel aquaporin-4 |
2.75 |
2.65 |
|
|
|
|
|
|
|
{titer} |
|
|
Release 2.67: COMPONENT: Updated "receptor" to "water channel" per current scientific nomenclature |
0 |
9082-9 |
Protein intake |
MRat |
^Patient |
8H |
Qn |
|
|
ACTIVE |
Protein intake 8 hour |
|
MIN |
DefinitionDescription |
|
|
g/8 hours |
|
|
|
|
|
|
IO_IN_SALTS+CALS |
|
9082-9 |
|
|
|
|
|
|
|
|
0 |
Protein intake 8h |
|
|
|
|
|
1/3 day; 8 hours; 8HR; IO_INTAKE_SALTS+CALORIES; Mass Rate; mRate; PR; Prot; QNT; Quan; Quant; Quantitative |
2.48 |
1.0i |
|
|
|
|
|
|
|
g/(8.h) |
|
|
|
0 |
90820-2 |
Contactin-associated protein 2 Ab |
PrThr |
CSF |
Pt |
Ord |
CBA IFA |
|
ACTIVE |
Contactin-associated protein 2 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
90820-2 |
|
CBA IFA |
|
|
Both |
|
|
|
0 |
CASPR2 Ab CSF Ql CBA IFA |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Assoc; Autoantibodies; Autoantibody; CASPR2; CASPR2 Ab; Cerebral spinal fluid; Cerebrospinal Fl; II; Indirect Fluorescence Antibody; Ordinal; Point in time; PR; Prot; QL; Qual; Qualitative; Random; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid |
2.69 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
90821-0 |
Contactin-associated protein 2 Ab |
Titr |
CSF |
Pt |
SemiQn |
CBA IFA |
|
ACTIVE |
Contactin-associated protein 2 Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
SERO |
|
90821-0 |
|
CBA IFA |
|
|
Both |
|
|
|
0 |
CASPR2 Ab Titr CSF CBA IFA |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Assoc; Autoantibodies; Autoantibody; CASPR2; CASPR2 Ab; Cerebral spinal fluid; Cerebrospinal Fl; Dilution factor; Dilution Factor (Titer); II; Indirect Fluorescence Antibody; Point in time; PR; Prot; Random; Serology; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Titer; Titered; Titre; Ttr |
2.75 |
2.65 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
90822-8 |
CV2 Ab |
ACnc |
CSF |
Pt |
Qn |
Line blot |
|
ACTIVE |
CV2 Ab [Units/volume] in Cerebral spinal fluid by Line blot |
|
MIN |
DefinitionDescription |
|
|
arb U/L |
|
|
|
|
|
|
SERO |
|
90822-8 |
|
Line blot |
|
|
Both |
|
|
|
0 |
CV2 Ab CSF Line blot-aCnc |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Collapsin response mediator protein 5; Collapsin response mediator protein 5 Ab; CRMP5; CRMP-5; Neuro; Neurology; Point in time; POP66; QNT; Quan; Quant; Quantitative; Random; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; ULIP |
2.7 |
2.65 |
|
|
|
|
|
|
|
[arb'U]/L |
|
|
|
0 |
90823-6 |
Dipeptidyl aminopeptidase-like protein 6 Ab |
PrThr |
CSF |
Pt |
Ord |
CBA IFA |
|
ACTIVE |
Dipeptidyl aminopeptidase-like protein 6 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
90823-6 |
|
CBA IFA |
|
|
Both |
|
|
|
0 |
DPPX Ab CSF Ql CBA IFA |
|
|
|
|
|
ABS; Aby; Amiopep; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Dipeptidyl peptidase-like protein 6; Dipeptidyl peptidase-like protein 6 Ab; DPPX; DPPX Ab; Indirect Fluorescence Antibody; Ordinal; Point in time; PR; Prot; QL; Qual; Qualitative; Random; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid |
2.69 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
90824-4 |
Dipeptidyl aminopeptidase-like protein 6 Ab |
Titr |
CSF |
Pt |
SemiQn |
CBA IFA |
|
ACTIVE |
Dipeptidyl aminopeptidase-like protein 6 Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
SERO |
|
90824-4 |
|
CBA IFA |
|
|
Both |
|
|
|
0 |
DPPX Ab Titr CSF CBA IFA |
|
|
|
|
|
ABS; Aby; Amiopep; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Dilution factor; Dilution Factor (Titer); Dipeptidyl peptidase-like protein 6; Dipeptidyl peptidase-like protein 6 Ab; DPPX; DPPX Ab; Indirect Fluorescence Antibody; Point in time; PR; Prot; Random; Serology; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Titer; Titered; Titre; Ttr |
2.75 |
2.65 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
90825-1 |
Gamma aminobutyrate B receptor Ab |
PrThr |
CSF |
Pt |
Ord |
CBA IFA |
|
ACTIVE |
GABABR Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
90825-1 |
|
CBA IFA |
|
|
Both |
|
|
|
0 |
GABABR Ab CSF Ql CBA IFA |
|
|
|
|
|
4-aminobutanoic acid; 4-aminobutyrate; 4-aminobutyric acid; ABS; Aby; Aminobutric; Aminobutyric; Amino-n-butyrate; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; GABA; GABABR; GABABR Ab; Gamma aminobutyric acid; Gamma amino-butyric acid; Gamma amino-n-butyrate; Gamma amino-n-butyric acid; Indirect Fluorescence Antibody; Ordinal; Piperidic acid; Point in time; PR; QL; Qual; Qualitative; Random; Rec; Recept; Receptors; Recp; Recptr; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid |
2.69 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
90826-9 |
Gamma aminobutyrate B receptor Ab |
Titr |
CSF |
Pt |
SemiQn |
CBA IFA |
|
ACTIVE |
GABABR Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
SERO |
|
90826-9 |
|
CBA IFA |
|
|
Both |
|
|
|
0 |
GABABR Ab Titr CSF CBA IFA |
|
|
|
|
|
4-aminobutanoic acid; 4-aminobutyrate; 4-aminobutyric acid; ABS; Aby; Aminobutric; Aminobutyric; Amino-n-butyrate; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Dilution factor; Dilution Factor (Titer); GABA; GABABR; GABABR Ab; Gamma aminobutyric acid; Gamma amino-butyric acid; Gamma amino-n-butyrate; Gamma amino-n-butyric acid; Indirect Fluorescence Antibody; Piperidic acid; Point in time; Random; Rec; Recept; Receptors; Recp; Recptr; Serology; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Titer; Titered; Titre; Ttr |
2.75 |
2.65 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
90827-7 |
Glial nuclear type 1 Ab |
PrThr |
CSF |
Pt |
Ord |
IF |
|
ACTIVE |
Glial nuclear type 1 Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
90827-7 |
|
IF |
|
|
Both |
|
|
|
0 |
Glial nuc type 1 Ab CSF Ql IF |
|
|
|
|
|
ABS; Aby; ACIF; AGNA; AGNA-1; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; FA; FANA; Fluorescent antibody; Fluoresent; Glial nuc type 1; i; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Lambert-Eaton myasthenic syndrome; Nuc; Ordinal; Paraneoplastic Antibody; Paraneoplastic syndrome; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Sox1; Sox1 nuclear antigen; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; TRF |
2.65 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
90828-5 |
Glial nuclear type 1 Ab |
ACnc |
CSF |
Pt |
Qn |
Line blot |
|
ACTIVE |
Glial nuclear type 1 Ab [Units/volume] in Cerebral spinal fluid by Line blot |
|
MIN |
DefinitionDescription |
|
|
arb U/L |
|
|
|
|
|
|
SERO |
|
90828-5 |
|
Line blot |
|
|
Both |
|
|
|
0 |
Glial nuc type 1 Ab CSF Line blot-aCnc |
|
|
|
|
|
ABS; Aby; AGNA; AGNA-1; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Glial nuc type 1; i; Lambert-Eaton myasthenic syndrome; Nuc; Paraneoplastic Antibody; Paraneoplastic syndrome; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Sox1; Sox1 nuclear antigen; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid |
2.7 |
2.65 |
|
|
|
|
|
|
|
[arb'U]/L |
|
|
|
0 |
90829-3 |
Glutamate decarboxylase 65 Ab |
ACnc |
CSF |
Pt |
Qn |
Line blot |
|
ACTIVE |
Glutamate decarboxylase 65 Ab [Units/volume] in Cerebral spinal fluid by Line blot |
|
MIN |
DefinitionDescription |
|
|
arb U/L |
|
|
|
|
|
|
SERO |
|
90829-3 |
|
Line blot |
|
|
Both |
|
|
|
0 |
GAD65 Ab CSF Line blot-aCnc |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Autoimmune myelopathy; c707; Cerebral spinal fluid; Cerebrospinal Fl; GAD; GAD65; GAD-65; GADA; Glu; Glutamic acid; Glutamic acid decarboxylase-65; Insulin-Dependent Diabetes Mellitus; Neuro; Neurology; Paraneoplastic neurological syndrome; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid |
2.7 |
2.65 |
|
|
|
|
|
|
|
[arb'U]/L |
|
|
|
0 |
9083-7 |
Protein intake |
MRat |
^Patient |
10H |
Qn |
|
|
ACTIVE |
Protein intake 10 hour |
|
MIN |
DefinitionDescription |
|
|
g/10 hours |
|
|
|
|
|
|
IO_IN_SALTS+CALS |
|
9083-7 |
|
|
|
|
|
|
|
|
0 |
Protein intake 10h |
|
|
|
|
|
10 hours; 10HR; IO_INTAKE_SALTS+CALORIES; Mass Rate; mRate; PR; Prot; QNT; Quan; Quant; Quantitative |
2.48 |
1.0i |
|
|
|
|
|
|
|
g/(10.h) |
|
|
|
0 |
90830-1 |
Leucine-rich glioma-inactivated protein 1 Ab |
PrThr |
CSF |
Pt |
Ord |
CBA IFA |
|
ACTIVE |
Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
90830-1 |
|
CBA IFA |
|
|
Both |
|
|
|
0 |
LGI1 Ab CSF Ql CBA IFA |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; i; Indirect Fluorescence Antibody; Leu; LGI1; LGI1 Ab; Ordinal; Point in time; PR; Prot; QL; Qual; Qualitative; Random; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid |
2.69 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
90831-9 |
Leucine-rich glioma-inactivated protein 1 Ab |
Titr |
CSF |
Pt |
SemiQn |
CBA IFA |
|
ACTIVE |
Leucine-rich glioma-inactivated protein 1 Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
SERO |
|
90831-9 |
|
CBA IFA |
|
|
Both |
|
|
|
0 |
LGI1 Ab Titr CSF CBA IFA |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Dilution factor; Dilution Factor (Titer); i; Indirect Fluorescence Antibody; Leu; LGI1; LGI1 Ab; Point in time; PR; Prot; Random; Serology; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Titer; Titered; Titre; Ttr |
2.75 |
2.65 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
90832-7 |
Ma+Ta Ab |
PrThr |
CSF |
Pt |
Ord |
IF |
|
ACTIVE |
Ma+Ta Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
90832-7 |
|
IF |
|
|
Both |
|
|
|
0 |
Ma+Ta Ab CSF Ql IF |
|
|
|
|
|
ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; MA1; MA-1; Ma2; MATA; Neuro; Neurology; Ordinal; Paraneoplastic Ag Ma 1; Paraneoplastic syndrome; PNMA1; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; TRF |
2.65 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
90833-5 |
Ma+Ta Ab |
ACnc |
CSF |
Pt |
Qn |
Line blot |
|
ACTIVE |
Ma+Ta Ab [Units/volume] in Cerebral spinal fluid by Line blot |
|
MIN |
DefinitionDescription |
|
|
arb U/L |
|
|
|
|
|
|
SERO |
|
90833-5 |
|
Line blot |
|
|
Both |
|
|
|
0 |
Ma+Ta Ab CSF Line blot-aCnc |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; MA1; MA-1; Ma2; MATA; Paraneoplastic Ag Ma 1; Paraneoplastic syndrome; PNMA1; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid |
2.7 |
2.65 |
|
|
|
|
|
|
|
[arb'U]/L |
|
|
|
0 |